The DWMRI/MRS Glioma Imaging Protocol Lars Ewell University of Arizona Medical Center Department of Radiation Oncology Faculty Research Meeting 6/23/08.

Slides:



Advertisements
Similar presentations
A phase I dose escalating study of intensity modulated radiation therapy (IMRT) for the treatment of glioblastoma multiforme (GBM) ( #1008) V. Stieber.
Advertisements

DIAGNOSTIC ROLE OF STATIC AND DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IN THE EVALUATION OF SOFT TISSUE TUMOURS Abstract No. IRIA
The Efficacy of Non-invasive Diagnostic for CAD in PMK Hospital Maj. Hutsaya Prasitdumrong, M.D. Cardiovascular Division, Department of Internal Medicine,
H. AlHussain, I. Busca, L. Eapen,, S. El-Sayed The Ottawa Hospital Cancer Center, University of Ottawa Department of Radiation Oncology.
McDaniels – Sept 12, Outline Uncertainty in ADC value Correction Manuscript.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Using Diffusion Weighted Magnetic Resonance Image (DWMRI) scans, it is possible to calculate an Apparent Diffusion Coefficient (ADC) for a Region of Interest.
The Dependence of the Apparent Diffusion Coefficient on Voxel Location and Calculation Method Lars Ewell 1, Naren Vijayakumar Meeting of the American.
1 Research Update LAE 9/26/08. 2 Uncertainty in Apparent Diffusion Coefficients Determined from Diffusion Weighted Magnetic Resonance Imaging
1 Research Update/Review LAE 5/23/08. 2 RIN/Recurrent Disease: The Problem T1 weighted contrast enhanced MRI taken 16 months after completion of radiotherapy.
Inferior Brain Lesions Monitored Using Diffusion Weighted Magnetic Resonance Imaging Lars Ewell 1, Naren Vijayakumar 2, Jeffrey J. Rodriguez 2 and Baldassarre.
Methods to Differentiate Radiation Induced Necrosis and Recurrent Disease in Gliomas Lars Ewell University of Arizona Medical Center Department of Radiation.
1 ADC Calculations Lars Ewell Radiation Oncology University of Arizona Medical Center 2/8/08 1.
Voxel Location Dependence of Brain Metabolites as Determined by Magnetic Resonance Spectroscopy L.Ewell, A. Bhullar and B. Stea—Department of Radiation.
1 Protocol Update LAE 6/6/ /23/07 – First patient enrolled Glioblastoma Multiforme (GBM) - scanned. Second scan on 5/8/07. Subsequent biopsy of.
1 Research Update LAE 8/22/08. 2 Uncertainty in Transcription of Lesion Contours to Diffusion Weighted Magnetic Resonance Images
DWMRI ADC Patient – Rhodes Four Exams. Rhodes 10 Contours 2 Lesions Exclusion Contour – Brain Stem.
1 Comparison of Different Diffusion Weighting Techniques Using Mutual Information Registration LAE 2/29/07.
DW-MRI and MRS to Differentiate Radiation Necrosis and Recurrent Disease in Gliomas P100 Exams 4224, SV, 2x2x2cm MV Thomas Chong.
McDaniels – Feb 29, Outline Patient 6 question Patient 11 ADC results Abstract for AAPM conference.
Metabolic Concentrations and Ratios of Brain Tissue Amarjeet Bhullar, Lars Ewell, Tim McDaniel and Baldassarre Stea Department of Radiation Oncology, The.
Choline/NAA Spatial Variation Lars Ewell Radiation Oncology University of Arizona Medical Center 1/25/08 1.
Method for Determining Apparent Diffusion Coefficient Values for Cerebral Lesions from Diffusion Weighted Magnetic Resonance Imaging Examinations T.H.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
Trevor Thang Department of Medical Biophysics, Western University QUALITY ASSURANCE OF MRI FOR ADAPTIVE RADIOTHERAPY: PRELIMINARY INVESTIGATIONS Six Week.
ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.
Tumor Localization Techniques Richard Kao April 10, 2001 Computer Integrated Surgery II.
Comparison of MRI Perfusion and PET-CT in Differentiating Brain Tumor Progression from Radiation Injury after Cranial Irradiation T. Jonathan Yang, M.D.
Progression-Free Interval After RFA of Lung Tumors Size Matters
Learn More At: Northwest Hospital Gamma Knife Center Dr. Sandra Vermeulen, M.D. Swedish Cancer Institute Northwest Hospital Gamma.
A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases.
H. Koivunoro1, E. Hippelänen1, I. Auterinen2, L. Kankaanranta3, M
PET in Colorectal Cancer. Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known.
DW-MRI and MRS to Differentiate Radiation Necrosis and Recurrent Disease in Gliomas Protocol MRS data status 11/27/07 – 12/17/07 Thomas Chong.
IsotropicAnisotropic ROLE OF DIFFUSION TENSOR IMAGING (DTI) IN INTRACRANIAL MASSES Abstract Number: 117.
Radiotherapy versus carboplatin for stage I seminoma: Updated analysis of the MRC/EORTC randomized trial Authors: Oliver et al,
Conflict of Interest Declaration: Nothing to Disclose Presenter: Sophie Lamoureux Title of Presentation: A Comparison of Stereotactic Body Radiotherapy.
Gamma Knife Kelly & Tarah.
Response evaluation in RCC Dr. Camillo Porta S.C. di Oncologia Medica I.R.C.C.S. Policlinico San Matteo, Pavia.
BRAIN GLIOMAS By:Tiphini Carroll. What causes Gliomas? The exact causes of gliomas are not known. Hereditary genetic disorders such as neurofibromatoses.
Department of Medical Imaging
University of Michigan Department of Radiology Role of MR Spectroscopy in Differentiating Radiation Necrosis from Tumor Recurrence. Effects of radiation.
M ETHODS Median dose was 22Gy (range: ) in 1 to 5 fractions Median treatment volume was 12.6 cc (range: ). Assessed for eligibility.
Purpose N-isopropylacrylamide (NIPAM) polymer gel dosimeters were employed to verify the dose distribution of clinical intensity modulated radiation therapy.
Role of Radiation Therapy in Brain metastasis Bongkot Supawongwattana, M.D. Division of Therapeutic Radiology and Oncology, Faculty of Medicine, Chiang.
Radiotherapy for SVC syndrome
The impact of age on outcome in early-stage breast cancer 방사선종양학과 R2. 최진현.
Medical Uses of Radioactivity
Atypical Teratoid Rhabdoid Tumor of the Third Cranial Nerve (AT/RT)
Dose–Volume Relationships Associated With Temporal Lobe Radiation Necrosis After Skull Base Proton Beam Therapy  Mark W. McDonald, MD, Okechukwu R. Linton,
Figure 1. A: T1-weighted MRI shows enhanced lesion with peripheral edema on left frontal area, compatible with high grade glioma. B: Left frontal area.
Tumour-Targeted Treatment Intensification for Prostate Cancer Using Magnetic Resonance Imaging Guidance  Jessy Abed, RTT, MHScMRS, Jenny Lee, MMath, Tim.
Supplement 1. This patient's horizontal magnetic resonance scan (left) and matched Talairach-Tournoux atlas image (right). Arrows show approximate areas.
Evaluation of biologically equivalent dose escalation, clinical outcome, and toxicity in prostate cancer radiotherapy: A meta-analysis of 12,000 patients.
Mary Jo Bowie MS, BS, AAS, RHIA, RHIT
The pathological diagnosis of diffuse gliomas: towards a smart synthesis of microscopic and molecular information in a multidisciplinary context  Pieter.
Figure 3 Risk-adapted and response-adapted
Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy by Georg.
Should we irradiate a brain tumor in a patient with parkinsonism
MRI Pulse Sequences: IR, EPI, PC, 2D and 3D
 (A) Diffusion weighted magnetic resonance imaging (MRI) scan of the brain of a full term male infant 56 hours after birth, showing parasagittal changes.
Should we irradiate a brain tumor in a patient with parkinsonism
Prophylactic Cranial Irradiation (PCI) versus Active MRI Surveillance for Small Cell Lung Cancer: The Case for Equipoise  Chad G. Rusthoven, MD, Brian.
Brian D. Williamson et al. JACEP 2017;3:
Rarer Bone Tumors Thomas F. DeLaney, M.D. Co-Director: Sarcoma Program
Incidence of contrast-induced nephropathy in patients with CKD, normal kidney function and all patients. Incidence of contrast-induced nephropathy in patients.
Figure 2 Kaplan-Meier survival graphs for 10-year risks of overall and post-90-day recurrent ischemic stroke (IS) and death Kaplan-Meier survival graphs.
Figure 1 Stacked bar chart depicts the proportion of patients with diffusion-weighted imaging (DWI)+ and DWI− scans categorized by index event type TIA.
Fig. 4 DMI visualizes the Warburg effect in a patient with GBM after oral [6,6′-2H2]glucose intake. DMI visualizes the Warburg effect in a patient with.
(A) High intensity lesions in the left dorsolateral midbrain on T2 weighted magnetic resonance imaging in case 1. (A) High intensity lesions in the left.
Presentation transcript:

The DWMRI/MRS Glioma Imaging Protocol Lars Ewell University of Arizona Medical Center Department of Radiation Oncology Faculty Research Meeting 6/23/08

2 The DWMRI/MRS Glioma Imaging Protocol I.Introduction II.Radiation Induced Necrosis/Disease III.Imaging Protocol IV.Initial Data V.Conclusion

The DWMRI/MRS Glioma Imaging Protocol: Introduction Designed to study whether or not Diffusion Weighted MRI and Magnetic Resonance Spectroscopy (MRS) can differentiate between radiation necrosis and recurrent disease. Enrolled first patient 3/23/07. See 3

Patients eligible to enroll if they have a reasonable risk of suffering from RIN. 4 DWMRI/MRS Protocol: Enrollment Criteria 1) Kumar et al., ‘Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy and Chemotherapy Induced Necrosis of the Brain After Treatment’, Radiology, 217, 2, November Published data 1 indicate that patients receiving a dose of  60Gy in 30 Fx have between a 5 and 24% chance of developing RIN.

Imaging Protocol: Enrollment Criteria Biological Equivalent Dose (BED) used to determine enrollment criteria for hypo- fractionation and SRS. 5 BED = nd(1 + ) with n the number of fractions, d the dose,  and  the linear quadratic constants. 5 x 6Gy required for hypo - fractionation, 21Gy for SRS.

6 Imaging Protocol: Enrollment Criteria Radiation TypeNumber of Fractions Minimum Radiation (Gy) SRS121 Hypo-fraction530 Normal Fraction3060 Re-treatmentvaries

7 Imaging Protocol: Scan Data Three MRS slices, one cm/slice: One centered on lesion, one superior and one inferior. Voxel size ~ 4cc. Set of three ‘diffrad’ DWMRI scans with b-values: 0, 520 and 850 s/mm 2. Set of two ‘echo planar’ DWMRI scans with b-values: 0, 1000 s/mm 2. Scan time approximately < one hour.

Protocol Patient Events CharacteristicNumber of Patients Deceased7 Withdrew3 One Scan16 Two Scans9 Three Scans3 Four Scans2 Biopsy1